NTAP
60
-4
PCAR
56
-5
MHK
46
12
WFC
72
4
BLK
49
5
VIX
69
-2
HD
37
6
BXP
38
4
PM
50
5
ETR
65
4
DHI
45
-9
PG
45
2
PRU
45
3
QCOM
69
-2
HSY
41
3
WM
70
8
ROK
47
-5
CMG
66
2
JCI
46
2
NOC
40
11
NTAP
60
-4
PCAR
56
-5
MHK
46
12
WFC
72
4
BLK
49
5
VIX
69
-2
HD
37
6
BXP
38
4
PM
50
5
ETR
65
4
DHI
45
-9
PG
45
2
PRU
45
3
QCOM
69
-2
HSY
41
3
WM
70
8
ROK
47
-5
CMG
66
2
JCI
46
2
NOC
40
11
Financhill
Back

Intellia Therapeutics Vs. Cassava Sciences Industry Stock Comparison

Sell
21

NTLA
Intellia Therapeutics

Last Price:
21.57
Seasonality Move:
34.64%
Sell
49

SAVA
Cassava Sciences

Last Price:
19.61
Seasonality Move:
1.87%
Sell
21
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $21.32. The Score for NTLA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy, Sell or Hold?

  • The current Cassava Sciences [SAVA] share price is $21.18. The Score for SAVA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SAVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $21.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.

SAVA Stock Price Chart

What is Cassava Sciences's stock price today?

  • The Cassava Sciences share price today is $21.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing slight selling pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.54 Sell
Relative Strength Index (14 RSI): 26.59 Sell
Chaikin Money Flow: -553731 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.64 - 27.64) Sell
Bollinger Bands (100): (25.35 - 30.59) Sell

SAVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 47.61 Sell
Chaikin Money Flow: -279552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.73 - 23.19) Sell
Bollinger Bands (100): (20.64 - 25.76) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.49 Sell
20-day SMA: 25.12 Sell
50-day SMA: 27.31 Sell
200-day SMA: 31.24 Sell
8-day EMA: 23 Sell
20-day EMA: 24.73 Sell
50-day EMA: 26.42 Sell
200-day EMA: 31.22 Sell

SAVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.79 Sell
20-day SMA: 21.46 Sell
50-day SMA: 21.96 Sell
200-day SMA: 21.34 Sell
8-day EMA: 21.82 Sell
20-day EMA: 21.79 Sell
50-day EMA: 22.02 Sell
200-day EMA: 22.74 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.02 per share.

Cassava Sciences Earnings Growth & SAVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $3.68 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cassava Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):